Closing Strong: Rocket Pharmaceuticals Inc (RCKT) Ends at 17.70, Up 0.45 from Last Close

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $17.62 in the prior trading day, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed at $17.70, up 0.45%. In other words, the price has increased by $0.45 from its previous closing price. On the day, 0.62 million shares were traded. RCKT stock price reached its highest trading level at $18.25 during the session, while it also had its lowest trading level at $17.42.

Ratios:

Our goal is to gain a better understanding of RCKT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.79 and its Current Ratio is at 7.79. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.

On April 02, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $39.

On October 24, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $65.Cantor Fitzgerald initiated its Overweight rating on October 24, 2023, with a $65 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 16 ’24 when Militello John sold 1,064 shares for $18.50 per share. The transaction valued at 19,688 led to the insider holds 51,451 shares of the business.

Patel Kinnari sold 3,989 shares of RCKT for $73,812 on Aug 16 ’24. The insider now owns 396,983 shares after completing the transaction at $18.50 per share. On Aug 16 ’24, another insider, Shah Gaurav, who serves as the CEO of the company, sold 9,650 shares for $18.50 each. As a result, the insider received 178,564 and left with 718,419 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 1610273536 and an Enterprise Value of 1349967616.

Stock Price History:

Over the past 52 weeks, RCKT has reached a high of $32.53, while it has fallen to a 52-week low of $15.98. The 50-Day Moving Average of the stock is -4.30%, while the 200-Day Moving Average is calculated to be -23.88%.

Shares Statistics:

The stock has traded on average 860.76K shares per day over the past 3-months and 696280 shares per day over the last 10 days, according to various share statistics. A total of 90.28M shares are outstanding, with a floating share count of 83.82M. Insiders hold about 7.87% of the company’s shares, while institutions hold 97.96% stake in the company. Shares short for RCKT as of 1727654400 were 11403110 with a Short Ratio of 13.25, compared to 1724976000 on 10929324. Therefore, it implies a Short% of Shares Outstanding of 11403110 and a Short% of Float of 26.610001999999998.

Most Popular